Smith & Nephew plc (LON:SN) Receives GBX 1,346.20 Consensus Price Target from Analysts

Shares of Smith & Nephew plc (LON:SN) have been assigned a consensus recommendation of “Moderate Buy” from the six research firms that are currently covering the stock, Marketbeat.com reports. One analyst has rated the stock with a hold rating and five have given a buy rating to the company. The average 12 month price objective among brokerages that have issued a report on the stock in the last year is GBX 1,346.20 ($16.91).

A number of analysts have issued reports on SN shares. Barclays reaffirmed an “equal weight” rating and issued a GBX 1,150 ($14.45) target price on shares of Smith & Nephew in a report on Friday, February 9th. Jefferies Financial Group restated a “buy” rating and issued a GBX 1,250 ($15.70) price objective on shares of Smith & Nephew in a research note on Friday. JPMorgan Chase & Co. upped their target price on shares of Smith & Nephew from GBX 1,300 ($16.33) to GBX 1,381 ($17.35) and gave the company an “overweight” rating in a research note on Thursday. Berenberg Bank restated a “buy” rating and issued a GBX 1,450 ($18.21) price target on shares of Smith & Nephew in a research report on Thursday. Finally, Royal Bank of Canada reaffirmed an “outperform” rating and set a GBX 1,500 ($18.84) price objective on shares of Smith & Nephew in a research report on Friday, April 5th.

Smith & Nephew Stock Performance

LON:SN opened at GBX 996.80 ($12.52) on Friday. The company has a current ratio of 1.77, a quick ratio of 0.84 and a debt-to-equity ratio of 59.11. Smith & Nephew has a 1 year low of GBX 887 ($11.14) and a 1 year high of GBX 1,316.75 ($16.54). The firm’s fifty day simple moving average is GBX 1,018.36 and its 200 day simple moving average is GBX 1,035.73. The firm has a market capitalization of £8.72 billion, a PE ratio of 4,153.33, a PEG ratio of 0.46 and a beta of 0.51.

Smith & Nephew Increases Dividend

The business also recently announced a dividend, which will be paid on Wednesday, May 22nd. Investors of record on Thursday, March 28th will be given a dividend of $0.23 per share. This represents a dividend yield of 1.62%. The ex-dividend date is Thursday, March 28th. This is an increase from Smith & Nephew’s previous dividend of $0.14. Smith & Nephew’s dividend payout ratio (DPR) is 12,500.00%.

About Smith & Nephew

Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom and internationally. It operates through three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. The company offers knee implant products for knee replacement procedures; hip implants for revision procedures; trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures; and other reconstruction products.